Sartorius AG (ADR)
General ticker "SSSGY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $14.5B (TTM average)
Sartorius AG (ADR) follows the US Stock Market performance with the rate: 23.3%.
Estimated limits based on current volatility of 0.0%: low 43.93$, high 43.93$
Factors to consider:
- Company pays dividends (annually): last record date 2026-03-30, amount 0.17$ (Y0.39%)
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [32.12$, 52.39$]
- 2026-12-31 to 2027-12-31 estimated range: [33.11$, 53.99$]
Financial Metrics affecting the SSSGY estimates:
- Negative: with PPE of 80.4 at the end of fiscal year the price was very high
- Positive: 7.78 < Operating profit margin, % of 18.41
- Negative: 19.10 < Shareholder equity ratio, % of 27.86 <= 42.34
- Positive: 0 < Industry operating cash flow per share per price (median), % of 1.58
- Negative: 0.75 < Interest expense per share per price, % of 1.49
- Positive: -4.44 < Investing cash flow per share per price, % of -3.88
Short-term SSSGY quotes
Long-term SSSGY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €3,395.70MM | €3,380.70MM | €3,398.46MM |
| Operating Expenses | €2,852.50MM | €2,943.50MM | €2,772.77MM |
| Operating Income | €543.20MM | €437.20MM | €625.69MM |
| Non-Operating Income | €-157.20MM | €-250.40MM | €-301.99MM |
| Interest Expense | €144.90MM | €205.40MM | €190.19MM |
| R&D Expense | €170.80MM | €196.80MM | €167.13MM |
| Income(Loss) | €386.00MM | €186.80MM | €323.70MM |
| Taxes | €95.90MM | €49.40MM | €102.39MM |
| Net Income(Loss)* | €205.20MM | €84.00MM | €148.79MM |
| Stockholders Equity | €2,067.30MM | €2,764.80MM | €2,705.65MM |
| Inventory | €1,036.70MM | €788.50MM | €791.86MM |
| Assets | €9,755.30MM | €10,103.00MM | €9,713.06MM |
| Operating Cash Flow | €853.60MM | €976.20MM | €630.11MM |
| Capital expenditure | €559.70MM | €409.90MM | €424.46MM |
| Investing Cash Flow | €-2,823.30MM | €-425.80MM | €-493.23MM |
| Financing Cash Flow | €2,165.70MM | €-128.30MM | €-394.39MM |
| Earnings Per Share** | €0.60 | €0.24 | €0.43 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.